What if you can’t tolerate azole antifungal medicines?

Last reviewed: April 2026

Key points

  • Azole antifungals are commonly used to treat aspergillosis, but not everyone tolerates them well.
  • “Azole intolerance” means the body reacts badly to the medication, even if it is otherwise effective.
  • Symptoms can include fatigue, flushing, shaking, nausea, and discomfort around the liver area.
  • In some cases, blood tests show changes in liver function.
  • If azoles are not tolerated, there are often alternative approaches your clinical team can consider.

Contents

What are azole antifungals?

Azole antifungals are a group of medicines used to treat fungal infections such as aspergillosis. They work by interfering with the fungal cell membrane, helping to stop the fungus growing.

Common examples include:

  • Fluconazole
  • Itraconazole
  • Voriconazole
  • Posaconazole

They are often used long-term in conditions like chronic pulmonary aspergillosis (CPA) or allergic bronchopulmonary aspergillosis (ABPA).

What is azole intolerance?

Azole intolerance means that a person develops unpleasant or harmful side effects when taking these medications, even at standard doses.

This is different from:

  • Allergy – an immune reaction (e.g. rash, swelling, breathing difficulty)
  • Resistance – when the fungus is not affected by the drug

With intolerance, the drug may still work against the fungus—but the body cannot tolerate its effects.

Why does azole intolerance happen?

There is no single cause. Instead, several factors can contribute:

1. How the body processes the drug

Azoles are broken down in the liver. People vary in how efficiently this happens, which can lead to higher levels of the drug in the body.

2. Effects on liver enzymes

Azoles affect enzymes (called cytochrome P450 enzymes) that are involved in processing many medications. This can:

  • Increase drug levels
  • Cause interactions with other medications
  • Put strain on the liver

3. Individual sensitivity

Some people are simply more sensitive to these drugs, even when blood levels are within the expected range.

4. Other health factors

  • Existing liver conditions
  • Age
  • Other medications
  • Nutritional status

Common symptoms to look out for

Patients describe a range of symptoms when azoles are not well tolerated, including:

  • Flushed or hot cheeks
  • Shaking or tremor
  • Severe fatigue
  • Nausea or reduced appetite
  • Discomfort or pain in the upper abdomen, back, or sides (where the liver sits)
  • General feeling of being unwell

These symptoms can appear soon after starting treatment or develop over time.

The role of the liver

The liver plays a central role in processing azole antifungals.

In some cases, this can lead to:

  • Raised liver enzymes on blood tests
  • Inflammation or irritation of the liver

It is important to note that:

  • Some people have abnormal blood tests without symptoms
  • Others feel unwell even when tests are only mildly changed

This is why both symptoms and blood tests are considered together.

What can be done if azoles are not tolerated?

If azole intolerance is suspected, your clinical team may consider several approaches:

Adjusting treatment

  • Reducing the dose
  • Changing how the medication is taken (e.g. with food)

Switching to another azole

Some people tolerate one azole better than another.

Therapeutic drug monitoring (TDM)

Blood tests can measure drug levels to help ensure they are not too high or too low.

Considering non-azole treatments

In some cases, different classes of antifungal medication may be considered.

The best approach depends on the individual, the condition being treated, and how severe the side effects are.

Why monitoring is important

Because azoles affect the liver and interact with other medications, monitoring is a routine part of care.

This may include:

  • Regular liver function blood tests
  • Drug level monitoring (for some azoles)
  • Review of other medications

Monitoring helps detect problems early and allows treatment to be adjusted safely.

Common questions

Does intolerance mean I cannot take any antifungal treatment?

No. Many patients who cannot tolerate one medication can use another, or a different approach may be possible.

Will the symptoms settle if I continue?

In some cases mild symptoms improve, but persistent or worsening symptoms should always be reviewed.

Is this common?

Most people tolerate azoles reasonably well, but intolerance is recognised and not rare in specialist clinics.

When to seek medical advice

You should contact your healthcare team if you experience:

  • Persistent or worsening fatigue
  • Pain in the upper abdomen, back, or sides
  • Nausea affecting eating or drinking
  • New or unusual symptoms after starting medication

Seek urgent medical attention if you notice:

  • Yellowing of the skin or eyes (jaundice)
  • Dark urine or pale stools
  • Severe abdominal pain

Summary

Azole antifungals are an important part of treating aspergillosis, but some people experience intolerance.

This is usually related to how the body processes the medication—particularly in the liver—and varies from person to person.

If intolerance occurs, it does not mean that treatment options have run out. With careful monitoring and specialist input, alternative strategies can often be found.

Further reading

Author & review

This article has been prepared for patients and carers using information aligned with UK specialist practice, including the National Aspergillosis Centre (Manchester, UK).

Important: This content is for general educational purposes only and is not a substitute for medical advice. Always speak to your healthcare team about your own situation.

by GAtherton

Why Join an Online Support Group if You Have Aspergillosis?

You are not alone with aspergillosis

Join a friendly online support meeting — no pressure, just listen if you prefer.

Many patients find that even attending once helps them feel more reassured, informed, and supported.


View meeting times and book your place

Why Join an Online Support Group if You Have Aspergillosis?

Living with aspergillosis can feel isolating. Many people go for years without meeting another person with the same condition. Family and friends may be supportive, but they may not fully understand what it is like to live with breathlessness, fatigue, treatment side effects, uncertainty, or repeated hospital visits.

That is one reason online support groups can be so valuable. They bring people together who understand, often immediately, many of the challenges that aspergillosis can bring.

Key points

  • Online support groups reduce isolation and help patients feel understood
  • They offer shared experience alongside emotional support
  • They improve confidence and understanding of the condition
  • They help patients feel better prepared for appointments
  • They are flexible — you can simply listen if you prefer

What changes when people join a support group?

Before joining

  • Feeling alone with the condition
  • Uncertainty about symptoms
  • Limited practical advice
  • Low confidence at appointments
  • Worry about the future

After joining

  • Connection with others who understand
  • Better understanding of the condition
  • Practical day-to-day coping ideas
  • More confidence asking questions
  • Feeling more supported and reassured

Why aspergillosis can feel so isolating

Aspergillosis is a relatively rare condition, and many patients never meet someone else with the same diagnosis. Online support groups help bridge that gap by creating a shared space for understanding and connection.

1. You realise you are not alone

Hearing others describe similar symptoms and challenges can be immediately reassuring and reduce feelings of isolation.

2. Shared experience can be deeply reassuring

Support groups provide practical, real-world insight into managing fatigue, pacing, work, and daily life.

3. You may understand your condition better

Listening to others and accessing shared resources helps build confidence and understanding.

4. It can help you feel more confident at appointments

Patients often feel better prepared and more able to ask the right questions.

5. Emotional support matters too

These groups provide encouragement, understanding, and a sense of belonging.

What happens in a typical online support session?

  • Friendly welcome — no pressure to speak
  • Open discussion — share or listen
  • Optional topics — such as fatigue or treatment experiences
  • Flexible participation — camera and microphone optional
  • Safe, moderated space

Many people attend their first session just to listen — and that is completely fine.

What patients often say

“I wish I had joined sooner. Just hearing others talk made a huge difference.”

“I didn’t speak in my first meeting, but it really helped just listening.”

“It helped me understand my condition and feel more confident.”

Thinking of joining?

You can attend once, listen, and decide if it feels helpful. There is no obligation to continue.

View meeting times and book here:

https://aspergillosis.org/support-meetings/

Meetings are held online using Microsoft Teams. You will receive a joining link after booking.

Bottom line

Online support groups offer connection, reassurance, and understanding. They cannot replace medical care, but they can make living with aspergillosis feel more manageable and less lonely.

Please note: These groups are for support and shared experience. They do not replace advice from your own doctor or specialist team.

by GAtherton

Understanding the Journey to Diagnosis (Start Here)

Last reviewed: 18 March 2026

Who this page is for: Patients, carers, and clinicians who want to understand why diagnosis can sometimes take time in aspergillosis and other chronic or complex conditions.
For many people, diagnosis is not a single moment. It is a journey.Symptoms may begin gradually, overlap with more common conditions, respond only partly to treatment, or take time to form a recognisable pattern. This can be confusing, frustrating, and sometimes frightening.This short series explores why that happens, what uncertainty can feel like, and why people are often not alone in having a long path to diagnosis.The series is written for patients and carers first, but we hope it will also help clinicians, families, and others understand the reality of the diagnostic journey more clearly.

Key points

  • Aspergillosis can be difficult to diagnose because symptoms often overlap with more common illnesses.
  • Long diagnostic journeys are common in many chronic and uncommon conditions, not just aspergillosis.
  • Uncertainty does not mean symptoms are unreal.
  • Diagnosis often becomes clearer over time, as symptoms, scans, tests, and patterns build up.
  • Good communication, ongoing review, and specialist input can make a major difference.
Different people may take different routes, but many share the same uncertainty before diagnosis becomes clear.

Why we created this series

People living with aspergillosis often tell us that the hardest part was not only the illness itself, but the time before they had an answer. Many describe repeated symptoms, multiple appointments, courses of treatment that only partly helped, and a growing sense that something still did not fit.

This experience is common in conditions such as chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA), but it is also seen much more widely across medicine.

We created this series to help make sense of that process in a way that is:

  • clear and accessible for patients and carers
  • respectful of clinicians working within complex systems
  • honest about uncertainty, delay, and emotional impact
  • useful for improving understanding on both sides

The articles in this series

1. Why Aspergillosis Is So Hard to Diagnose

This article explains why aspergillosis can be difficult to recognise, why medicine usually starts with more common explanations, and how diagnosis often depends on patterns building up over time rather than one single test.

Best for: understanding the overall process and why delays can happen.

2. When Symptoms Are Real but Answers Are Not: Understanding Uncertainty

This article looks at the emotional and communication side of the diagnostic journey, including why patients may feel unheard, what clinicians may mean when they speak cautiously, and why unexplained symptoms are still real symptoms.

Best for: understanding uncertainty, communication gaps, and the experience of not yet having answers.

3. Why Diagnosis Can Take Time — and Why You Are Not Alone

This article places the diagnostic journey in a wider context, showing that long paths to diagnosis are common in many chronic and complex conditions, and offering reassurance that patients are not alone in this experience.

Best for: reassurance, perspective, and recognising that this journey is shared by many others.

Who may find this series helpful

This series may be useful if you are:

  • a patient with ongoing respiratory symptoms and no clear diagnosis yet
  • a carer or family member trying to understand what your loved one is going through
  • a person recently diagnosed with aspergillosis and looking back on a long journey
  • a general practitioner, respiratory clinician, nurse, or allied health professional wanting to better understand the patient perspective

It may also help people with other chronic conditions, because many of the same themes—uncertainty, overlap of symptoms, repeated reassessment, and eventual recognition—are seen across a wide range of illnesses.

When to seek medical advice

Seek medical advice if you have ongoing or worsening symptoms that are not improving as expected, especially if they keep returning or no longer fit the original explanation.

Seek urgent medical advice if you have symptoms such as:

  • coughing up blood
  • rapidly worsening breathlessness
  • new chest pain
  • significant unexplained weight loss
  • high fever or signs of severe infection

If you already have an underlying lung condition and your usual treatment no longer seems to be working, it is reasonable to ask whether the diagnosis needs to be reviewed.

A final thought: a long path to diagnosis can feel isolating, but it is a recognised part of many chronic illnesses. Better understanding can help patients feel less alone and help clinicians recognise these journeys more clearly.

by GAtherton

Using AI Safely When You Have Aspergillosis

Artificial intelligence (AI) tools (for example, ChatGPT and other “medical chatbots”) can help people living with aspergillosis understand information, prepare for appointments, and feel more confident asking questions.

Used well, AI can be like a helpful explainer.
Used badly, it can be misleading — especially for conditions like aspergillosis where treatment decisions are complex.

This page explains what is safe, what is not safe, and how to use AI in a way that supports (not replaces) your clinical team.

Who is this page for?

This guidance is for people affected by:

  • Chronic Pulmonary Aspergillosis (CPA)

  • Allergic Bronchopulmonary Aspergillosis (ABPA)

  • Severe Asthma with Fungal Sensitisation (SAFS)

  • Aspergillus bronchitis

  • Other long-term Aspergillus-related lung problems

A simple rule that keeps you safe

AI should improve your understanding — it should not change your treatment.

If an AI tool suggests starting, stopping, or changing medication, do not act on it without speaking to your clinician.

What AI is good for

AI tools are usually helpful for:

Explaining medical words in plain language

Examples:

  • “What is Aspergillus Immunoglobulin G (IgG)?”

  • “What does ‘eosinophils’ mean?”

  • “What is a CT scan finding such as ‘cavity’ or ‘bronchiectasis’?”

Understanding medicines (general information)

AI can explain:

  • What a medicine is for

  • How it works in the body

  • Common side effects (in general terms)

  • Why monitoring is needed

This can be helpful for antifungal medicines such as itraconazole, voriconazole, posaconazole, and isavuconazole.

Preparing for appointments

AI can help you create a list of questions, for example:

  • “What monitoring do I need while on antifungals?”

  • “What symptoms should prompt urgent review?”

  • “How do we judge whether treatment is working?”

Summarising research articles

If you paste a paragraph from a paper (or describe it), AI can often translate it into patient-friendly language.
(Always remember: AI can sometimes get details wrong — see below.)

Organising your story

Many people find it useful to ask AI to format:

  • A timeline of symptoms

  • A list of medicines and dates

  • A short “what I want from this appointment” summary

This can make consultations more productive.

What AI is NOT safe for

AI should not be used for:

Diagnosis

Aspergillosis diagnosis usually depends on a careful combination of:

  • Symptoms and clinical history

  • Imaging (often computed tomography, CT)

  • Blood tests

  • Sputum tests / microbiology

  • Sometimes bronchoscopy results

AI cannot reliably “diagnose” from symptoms or a single test result.

Treatment decisions

Do not use AI to decide:

  • Whether you should start or stop antifungals

  • Steroid doses or tapering plans

  • Whether you “should” try biologics (for example, omalizumab)

  • Whether a side effect is safe to ignore

These decisions must be individualised and clinician-led.

Urgent situations

If you have worsening breathlessness, fever, chest pain, or coughing blood (haemoptysis), seek medical advice urgently.
AI is not an emergency service.

Why aspergillosis needs extra caution

Aspergillosis care can be complicated because:

  • Some antifungal medicines have important drug interactions

  • Blood levels may need monitoring (therapeutic drug monitoring)

  • Side effects can overlap with symptoms of lung disease

  • Different Aspergillus-related conditions can look similar but need different management

AI tools can also:

  • Over-generalise from asthma guidance

  • Confuse chronic disease with invasive disease

  • “Hallucinate” (invent) facts, references, or confident-sounding explanations

  • Be out of date

Privacy and confidentiality: what not to share with AI

To protect your privacy, avoid typing in:

  • Your full name

  • Date of birth

  • NHS number

  • Home address

  • Phone number

  • Identifiable clinic letters or reports (unless anonymised)

A safer way to write questions

Instead of pasting an entire letter, use a summary like:

“Adult with chronic lung disease, on itraconazole 200 mg daily, recent CT shows cavities, asking about monitoring and side effects.”

That’s usually enough for education and planning questions.

A safe “4-step” way to use AI

  1. Ask AI to explain (terms, tests, general concepts)

  2. Ask AI to help you prepare questions

  3. Discuss those questions with your clinician

  4. Only change treatment after clinical advice

A quick safety checklist

Before trusting an AI answer, ask:

  • Is this general education, or is it telling me what I should do?

  • Does it recommend changing my medicine or dose?

  • Does it mention checking interactions or monitoring?

  • Does it conflict with my current plan?

  • Is this situation urgent?

If any answer worries you: pause and ask your care team.

Example prompts patients can use safely

You can copy/paste these into an AI tool:

  • “Explain Chronic Pulmonary Aspergillosis (CPA) in plain language.”

  • “What questions should I ask about long-term itraconazole treatment?”

  • “What monitoring is commonly recommended for antifungal medicines?”

  • “Can you help me write a one-page symptom and medication summary for my clinic appointment?”

  • “Here is a paragraph from a research paper — can you summarise it in patient-friendly language and list any uncertainties?”

Tip: If you want a more cautious response, add:
“Please be conservative and tell me what you’re unsure about.”

Signs an AI answer may be unreliable

Be cautious if the AI:

  • Sounds very confident but gives no clear reasoning

  • Gives exact doses or taper schedules

  • Claims “this is definitely ABPA/CPA” from limited information

  • Provides references you cannot find elsewhere

  • Dismisses side effects, interactions, or monitoring

  • Encourages you to delay medical care

Final reminder

AI can be a helpful tool for understanding and preparing — but it is not a substitute for a specialist team.

If you are unsure, or something feels wrong, it is always reasonable to contact your clinician, specialist nurse, or GP.

Medical disclaimer

This page is for general information only and is not medical advice. Always follow the guidance of your healthcare team, especially regarding diagnosis, medicines, and urgent symptoms.

by GAtherton

Remediation, verification, and refusal to move you

Home › Knowledge Hub › Damp, mould and aspergillosis › Remediation & refusal to move

If remediation is done but symptoms persist or worsen, the key question becomes: has the home been demonstrated to be safe to occupy?

What “good remediation” should include

  • Cause fixed: leak/ingress/defect repaired, not just cleaned.
  • Drying: adequate drying time and moisture checks.
  • Material decisions: water-damaged porous materials removed where needed.
  • Safe work: dust/spore spread controlled (important for medically vulnerable households).
  • Verification: documented checks that work is complete and the home is safe.

Red flags (“bad remediation”)

  • Paint over staining or “mould spray” only
  • No drying plan, no moisture measurements
  • No documentation of what was removed/replaced
  • Work that creates dust without protection/containment
  • Refusal to provide any meaningful post-remediation checks

If symptoms worsen after remediation

Worsening symptoms can occur if contaminated materials were disturbed or if damp persists behind walls/floors. This is a strong indicator that the hazard may not be resolved.

Actions:

  1. Document symptoms and healthcare visits (Page 3 template).
  2. Ask landlord for written evidence of safety and remediation details.
  3. Request escalation to Environmental Health if unresolved.

If the landlord refuses to move you (decant)

Use this framing:

  • The issue is not “repairs completed” — it is safety and health risk.
  • Ask: “What evidence shows the home is safe to occupy?”

Template request for temporary alternative accommodation

Subject: Request for temporary alternative accommodation (health risk / damp and mould)

Hello [Name/Team],

Despite remediation work, we are experiencing ongoing damp/mould concerns and worsening health symptoms in a clinically vulnerable household.

Please provide written evidence that the home is safe to occupy, including:
- confirmation the moisture source has been resolved,
- evidence of drying/moisture checks,
- what materials were removed/replaced,
- what post-remediation checks were completed.

Given the uncertainty around safety and the health impacts, we are requesting temporary alternative accommodation until the property can be demonstrated to be safe to occupy.

Kind regards,
[Name]

If you return “under protest”

If you have no alternative but to return, keep it in writing:

We are returning to the property due to lack of alternative accommodation. We do not accept that the damp/mould hazard has been resolved and will continue to document health impacts and seek independent assessment.

by GAtherton

❤️ Thinking About Donating Blood After Aspergillosis or Lung Treatment?

A supportive message for people living with ABPA, CPA, SAFS, and related lung conditions

When you live with aspergillosis or a long-term lung condition, you know what it means to go through difficult treatments, long recoveries, and moments of uncertainty.
So when someone says, “Once I’m well, I’d like to donate blood to help others,” it is an incredibly generous and hopeful act.

Many people in our community wonder whether blood donation is possible after lung surgery, long-term inhalers, antifungals, or biologics. The reassuring answer is:

👉 Yes — some aspergillosis patients can donate blood once fully recovered, but it depends on individual treatments and health status.

And even if you can’t donate, the spirit behind the idea is powerful and meaningful.

🌱 1. Recovery comes first — your health is the priority

Whether you’ve had:

  • ABPA flare-ups

  • CPA treatment

  • bronchoscopy

  • long-term antifungals

  • biologics

  • a lobectomy or wedge resection

…the NHS will want you to be:

  • fully healed

  • breathing comfortably

  • stable in your lung condition

  • free from infection

  • strong enough to safely donate

For major surgery like a lobectomy, this often means several months of recovery before you can even be reviewed for donation.

This protects your health, not just the receiver’s.

💊 2. Medications commonly used for aspergillosis can affect eligibility

NHS Blood and Transplant will look closely at what you’re taking.

Here’s a simple guide:

Often NOT permitted

  • Biologics (e.g., mepolizumab, benralizumab, dupilumab)

  • Long-term immunosuppressants

  • Regular systemic steroids

May require a delay after stopping

  • Itraconazole / voriconazole / posaconazole

  • Recent antibiotic courses

  • Short steroid bursts

Usually fine

  • Inhalers

  • Nebulised saline

  • Montelukast

  • Airway clearance treatments

  • Most pain medicines

Every case is assessed individually — there is no automatic “yes” or “no” for all aspergillosis patients.

🫁 3. Your lung condition does not automatically exclude you

Having ABPA, CPA, bronchiectasis, or SAFS does not automatically prevent blood donation.

What matters is:

  • your condition is stable

  • your oxygen levels are good

  • you are not prone to sudden flare-ups

  • you feel well and strong

Many people with asthma or mild-to-moderate bronchiectasis still donate safely.

🩸 4. Your blood type is always valuable

Whether you’re a universal donor type (O-negative) or any other type, your blood can help save lives.

Even wanting to donate is something to be proud of — especially after everything you’ve been through.

🌟 5. The intention to donate speaks volumes about your strength

People living with aspergillosis know:

  • what it means to struggle for breath

  • how it feels to wait for test results

  • the exhaustion of flare-ups

  • the courage needed for surgery

  • the patience required for long-term treatment

So when someone in this community says:

“If I recover well, I want to donate blood to help someone else.”

…it’s a truly inspiring message of recovery and generosity.

🌈 6. Even if you can’t donate — your kindness still matters

Because of medications or long-term conditions, some people with aspergillosis will be told they can’t donate blood. This is completely normal.

You can still help others by:

  • encouraging friends or family to donate

  • sharing your story to raise awareness

  • supporting patient groups, campaigns, and research

  • simply being there for someone newly diagnosed

Your contribution to the world is not measured by a needle — it’s measured by your compassion.

❤️ Takeaway message

If you want to donate blood after aspergillosis treatment or lung surgery, that’s a beautiful intention. When you’re fully recovered, the NHS can review your health and medications. Whether you can donate or not, the willingness to help others already makes a real difference.

by GAtherton

⭐ How to Avoid Being Fooled by Misleading Products, Private Tests and Health Claims

A practical, evidence-based guide for people living with aspergillosis, asthma, bronchiectasis and COPD

People with long-term lung conditions are often targeted by persuasive marketing, “health influencers”, alternative practitioners, and private test companies.
These services frequently exploit fear, frustration, and the very understandable desire for answers.

This expanded guide explains why certain products look scientific, why most are biologically impossible, and how you can protect yourself from being misled or spending money on things that cannot help your condition.

This is about empowerment — never about blaming patients.

🧩 1. Why misleading products look convincing

Companies deliberately use wording and imagery that trigger trust:

  • lab coats

  • microscopes

  • graphs and biological diagrams

  • words like “antifungal”, “immune”, “toxins”, “wellness”, “clinical strength”

These features make a product appear evidence-based — but appearance is not evidence.

Many claims contain a grain of truth, e.g.:

  • “Tea tree oil kills fungus in the lab”

  • “Silver has antimicrobial properties”

  • “This herbal extract reduces inflammation in laboratory tests”

But the missing information is the critical part:

⭐ The lab conditions have nothing to do with the human body.

To “kill fungus in a dish”, companies use concentrations that:

  • would be toxic in humans

  • cannot reach the lung tissue

  • would be broken down in the gut or bloodstream

  • do not survive into the airways

Companies rely on the fact that most customers don’t know this.

🧬 2. “Plausibility comes before testing” — the rule companies hope you don’t know

Scientists follow a simple chain:

1️⃣ Is it plausible?
Can the substance reach the lung?
Does the pathway make sense?

2️⃣ If yes — test it.
If not — don’t.

Products sold online almost always fail at Step 1.

Examples:

Turmeric supplements

Even at huge oral doses, only a tiny amount enters the bloodstream — nowhere near the lung in meaningful levels.

Oregano oil

Kills fungi on metal plates in labs — but the amount needed inside the lung would be toxic.

Silver products

Irritate the lungs and accumulate in tissues — highly implausible as therapy.

Essential oils

Break down long before reaching the airways in meaningful amounts.

Herbal antifungals

Often metabolised by the gut and liver — never reach airways at therapeutic levels.

This is why clinical trials don’t happen —
not because no one has tried,
but because there’s no scientific reason to bother.

🛍️ 3. How companies use “allowed” claims to sound medical

Because these products are not classed as medicines, they must not claim to “treat disease”.
So companies use vague, legally safe wording:

  • “Supports immunity”

  • “Maintains wellness”

  • “Promotes respiratory health”

  • “Contains antifungal botanicals”

  • “Helps with mould exposure”

  • “Advanced detox science”

All of these sound medical but say nothing measurable.

Example:

A supplement cannot say:

  • “Improves aspergillosis symptoms”

But it can say:

  • “Supports healthy immune response”

This tricks the viewer into mentally connecting the dots without the company making any illegal claims.

🧊 4. Air filters — the rare partial exception

Air purifiers can help some people, because they reduce:

  • dust

  • pollen

  • irritants

  • pet dander

  • airborne particulate matter

These changes may ease coughing or wheezing in sensitive people.

BUT…

most devices sold online are far too weak.

A purifier needs:

  • True HEPA H13 filter (not “HEPA-type”)

  • CADR 250–350+ for most rooms

  • Strong fan to turn over room air 4–5 times per hour

Without these, a purifier is just an expensive fan.

What they cannot do:

  • cure aspergillosis

  • remove Aspergillus from the lungs

  • prevent exposure

  • substitute for ventilation

  • fix damp or mould in walls

They improve comfort, not disease.

👩‍⚕️ 5. Why alternative practitioners are so persuasive

Alternative practitioners often:

  • speak with confidence

  • promise personalised care

  • provide long consultations

  • listen sympathetically

  • use scientific-sounding language

  • offer simple explanations for complex symptoms

Their tests and treatments look legitimate, but the problems include:

❌ No training in lung disease

❌ Misunderstanding of immunology

❌ Misuse of lab dish studies

❌ Incorrect interpretation of “toxins”

❌ Selling supplements with no evidence

❌ Recommending dangerous inhaled substances (e.g., oils, peroxide)

❌ Relying on anecdotes, not data

Even well-meaning practitioners can unintentionally cause:

  • lung irritation

  • drug interactions

  • adrenal effects

  • delays in proper NHS treatment

  • unnecessary fear

🧪 6. Private test companies — why their results look real but mean nothing

Common private tests include:

  • mycotoxin urine tests

  • “mould illness panels”

  • detox pathway testing

  • food IgG tests

  • fungal metabolite tests

  • heavy metal hair analysis

  • “immune balance” panels

  • testosterone finger-prick kits

These results are presented with:

  • charts

  • colour-coded ranges

  • expert-sounding commentary

But the key issue is:

⭐ The reference ranges are invented by the company.

Often “high” simply means:

  • “higher than the average of people who bought this test”

Not:

  • higher than healthy people

  • higher than unwell people

  • linked to disease

GPs and consultants cannot act on these results because they are not medically interpretable.

👨‍⚕️ 7. Testosterone tests — a perfect illustration of misleading health screening

Companies advertise:

  • “Tired? Low mood? Low motivation?”

  • “Check your testosterone at home”

  • “Feel younger again”

They use US-style messaging that implies easy treatment.

But in the UK, testosterone treatment requires:

  • symptoms consistent with hypogonadism

  • two morning venous blood tests

  • validated hospital labs

  • endocrine specialist interpretation

  • ruling out multiple other causes

  • testosterone levels fall slowly as part of ageing - it is normal

Finger-prick tests do not meet NHS criteria,
so patients end up:

  • anxious

  • misinformed

  • sold supplements

  • not eligible for NHS treatment

This perfectly mirrors the broader pattern of private testing.

🔍 8. The “curiosity gap”: why people buy tests that GPs won’t order

Patients understandably feel:

  • frustrated

  • curious

  • confused

  • not listened to

  • desperate for answers

When a GP says “That test won’t help,” it can feel like:

  • rejection

  • dismissal

  • obstruction

But the reality is:

⭐ GPs are following evidence-based pathways to protect you.

Most private tests:

  • do not answer a clinical question

  • have false positives

  • trigger unnecessary follow-up scans

  • cause anxiety

  • cannot be interpreted

  • do not influence treatment

Private companies exploit:

  • curiosity

  • frustration

  • the desire for answers

  • the emotional gap left by long waits or unexplained symptoms

But a meaningless test result is worse than no test at all.

🧾 9. Real-world examples: 15 common traps to avoid

1. Mould settle plates

All rooms grow mould on plates — totally meaningless for health.

2. IgG food sensitivity tests

Measure normal immune exposure, not allergies.

3. Finger-prick vitamin tests

Often inaccurate and label normal levels as “borderline”.

4. Lung detox drinks

Nothing you drink detoxes the lungs.

5. Hydrogen peroxide / silver nebulisers

Dangerous. Irritate lungs. Risk chemical burns and pneumonitis.

6. Essential oil diffusers marketed as “antifungal”

Irritate airways; no delivery to lung tissue.

7. Mycotoxin detox programmes

Based on non-diagnoses; push expensive supplements.

8. Immune-boosting products

No supplement boosts immunity in a useful way for aspergillosis.

9. “Black mould blood tests”

No such test exists; ranges are invented.

10. Ozone machines and air ionisers

Harmful to lungs; zero evidence.

11. Anti-mould paint additives

Mask damp; do not impact indoor fungal counts long term.

12. Red-light therapy devices

Cannot penetrate tissue; no lung benefit.

13. Detox foot patches

Turn brown from sweat; total scam.

14. Anti-mould laundry boosters

Irrelevant to aspergillus exposure.

15. Humidifiers sold for “lung support”

Raise humidity → increase mould risk.

🛡️ 10. The Anti-Fooling Checklist

Before you buy anything, ask:

✔ Has this been tested in people with aspergillosis?

✔ Can it physically reach the lungs?

✔ Does NHS medicine recognise or use it?

✔ Are the claims vague? (“supports immunity”)

✔ Are the reference ranges medically valid?

✔ Would my consultant recommend this?

✔ Is this a simple answer to a complex condition?

If any answer is no, it’s a red flag.

⭐ 11. Golden rule

If a treatment or test genuinely helped aspergillosis, your consultant would already be using it —
not influencers, Amazon sellers, or unregulated US labs.

🌟 12. Final message: It’s not foolishness — it’s human

You are not being “tricked” because you’re naïve.
These products are engineered to be emotionally irresistible.
People with chronic illness are targeted because they are thoughtful, curious, and trying hard to get better.

If you are ever unsure about a product or test:

  • ask NAC/CARES

  • ask your specialist

  • or bring it to your next appointment

You deserve real answers — not false hope.

by GAtherton

Why Exposure to Young Children Can Increase Illness in Aspergillosis, ABPA, and Bronchiectasis — and How to Track Viral Outbreaks

Many patients with Allergic Bronchopulmonary Aspergillosis (ABPA), aspergillus-related asthma, or bronchiectasis notice that they become ill far more often when spending time around younger children. This applies whether you work with them, live with them, or spend time with grandchildren or family groups. Here’s why it happens, what other patients experience, and how to monitor viral outbreaks so you can protect yourself.

Why Young Children Increase Illness Risk

1. Young children spread far more respiratory infections

Children under 11:

  • Carry more colds, viruses, and respiratory bugs

  • Shed viruses for longer periods

  • Have high viral loads

  • Are still learning hygiene habits

  • Spend a lot of time in close physical contact with adults

Even small viral infections can cause major lung flares in ABPA and bronchiectasis.

2. Viral infections trigger flare-ups, exacerbations, and pneumonia

With:

  • Bronchiectasis → mucus doesn’t clear properly, so infections “stick”

  • ABPA → airways are inflamed, reactive, and mucus-filled

  • Asthma → viruses are the most common exacerbation trigger

A simple cold in a child can turn into:

  • Fever

  • Chest infection

  • Need for antibiotics

  • Pneumonia

  • Weeks of recovery

This pattern is extremely common.

3. Children spread viruses even when only mildly ill

Some viruses (RSV, adenovirus, flu) spread before symptoms, or for many days after a child appears well.

Adults with lung conditions may experience far more severe symptoms from these same infections.

4. Any indoor, close-contact time increases risk

This includes:

  • Teaching music or classroom work

  • Caring for grandchildren

  • Sitting in cars together

  • Birthday parties, playgroups, soft play

  • Family gatherings

  • Living in the same household

Even short exposures can be enough in winter months.

What Other Aspergillosis Patients Report

Across support groups and clinics:

  • Many patients stay well until grandchildren reach nursery/school age.

  • Switching from high school to primary/elementary teaching often leads to repeated infections.

  • People frequently report more pneumonias in winter when around young children.

This is very common and not your fault.

How to Reduce Risk (Realistically)

1. Improve ventilation

  • Open windows/doors during visits or lessons

  • Use a HEPA air purifier at home or work

  • Avoid long stays in small rooms

2. Control exposure without avoiding children

Shorter visits with good ventilation are safer than long indoor contact.

3. Keep up with airway clearance routines

Vital for preventing infections from settling.

4. Mask during periods of high virus circulation

Especially when RSV, flu, COVID, or “winter bugs” are rising.

5. Stay vaccinated

Flu, pneumococcal, COVID (if eligible), and pertussis if around infants.

6. Get medical review if you're repeatedly unwell

Your team may consider:

  • Prophylactic antibiotics

  • Nebulised saline

  • Optimising inhalers/biologics

  • Checking ABPA control

7. Use Occupational Health if exposure is workplace-related

Ask for:

  • Teaching older groups

  • Ventilation improvements

  • Reduced winter exposure

Where to Get Reliable Information on Viral Outbreaks

Tracking viral activity can help you plan safer weeks and reduce the chance of flare-ups.

1. UK Health Security Agency (UKHSA)

Weekly reports on:

  • Flu

  • COVID

  • RSV

  • Measles and other outbreaks

  • Regional activity levels

Best official national overview. Link

2. GOV.UK Infectious Disease Reports

Lists:

  • Confirmed outbreaks

  • Public health warnings

  • School/nursery clusters

  • Localised alerts

3. Local NHS Trust or ICB Websites

Many publish:

  • Weekly respiratory dashboards

  • Local flu/RSV alerts

  • Outbreak notices for schools and care settings

(Example: Greater Manchester ICB has regular respiratory activity updates.)

4. GP Surgeries & NHS App Alerts

GPs can push:

  • Local viral alerts

  • Flu surges

  • Measles/strep notifications

Often one of the earliest local signals.

5. School/Nursery Letters and Newsletters

Schools must notify families about:

  • Flu/strep outbreaks

  • High absence levels

  • Confirmed clusters

Very useful if you work with or spend time around children.

6. Zoe Health Study App

Crowd-sourced, real-time data on:

  • Colds

  • Flu-like illness

  • COVID

  • Regional spikes

Good for early warning.

7. Local Council Public Health

Check:
[Your council] + “Public Health”
They often post:

  • Local outbreak alerts

  • Enhanced infection-control notices

  • Community virus trends

8. NHS 111 Online Data

Shows real-time spikes in:

  • Cough

  • Fever

  • Chest infections

  • Sore throat or strep symptoms

A useful snapshot of local trends.

Key Message

Yes — any exposure to young children can raise infection risk when you have aspergillosis, ABPA, or bronchiectasis.
Tracking viral outbreaks helps you plan safer contact, adjust your activities, and reduce the chance of pneumonia or flare-ups.

Resources

Here are direct links to trusted resources you can use to monitor viral outbreaks and infection risk (especially helpful for those with ABPA, bronchiectasis, asthma, and other lung conditions):

by GAtherton

Understanding Risk from Aspergillosis — and What’s Improving

🧫 How risky is aspergillosis?

The outlook for people with aspergillosis has improved dramatically in the past two decades.
Two things have changed that make a huge difference:

  1. We diagnose it earlier.
    Better scans, blood tests (like galactomannan and PCR), and greater awareness mean the infection or allergic reaction is recognised much sooner.

  2. We treat it better.
    Modern antifungal medicines, steroid-sparing biologics, and specialist clinics have all transformed care and monitoring.

⚖️ Risk of death — managed vs. unmanaged

Type of Aspergillosis If well managed If unmanaged or poorly treated
Allergic (ABPA) Survival > 95 % About 90 % (may progress to chronic lung damage)
Chronic (CPA) 5-year survival ≈ 80–90 % 5-year survival ≈ 50 %
Invasive (IA) 5-year survival ≈ 50–70 % < 20 % (often fatal if untreated)

Across all forms of aspergillosis, the risk of death has fallen by roughly 50 % since the early 2000s.

💊 What’s driven this improvement

  • New antifungal drugs — triazoles (itraconazole, voriconazole, posaconazole, isavuconazole) now form the backbone of long-term therapy.

  • Rapid diagnosis — galactomannan, PCR, and CT scanning detect infection days earlier than before.

  • Improved hospital and ICU care — faster recognition and better ventilation strategies save lives in invasive cases.

  • Specialist clinics and monitoring — regular blood tests, imaging, and drug-level checks prevent deterioration and drug toxicity.

  • Biologic therapies — agents that target allergic inflammation (like anti-IgE or anti-IL-5 biologics) help reduce steroid use and preserve lung function.

🚀 What could make outcomes even better

Researchers and clinicians are optimistic about the next decade.
Future advances are already on the horizon:

Future area How it helps
Next-generation antifungals – Olorofim, Fosmanogepix Active against azole-resistant strains and safer for long-term use
Combination or personalised therapy Matching the right drug and dose to each patient’s response pattern
Routine antifungal-resistance testing Prevents treatment failure by identifying resistant Aspergillus early
Rapid home or bedside testing Detects infection flare-ups before symptoms become severe
Improved imaging and AI-supported analysis Spots fungal cavities or airway changes at an earlier, reversible stage
Global stewardship of agricultural azoles Reduces environmental resistance by limiting unnecessary fungicide use
Patient self-monitoring and digital follow-up Enables early reporting of symptoms and better long-term adherence

⚠️ Potential barriers to further progress

Even with all these advances, several important challenges could slow improvement if left unaddressed:

Barrier Why it matters
Antifungal resistance Aspergillus fumigatus is developing resistance to azoles used both in medicine and agriculture. Resistant strains can make first-line treatment fail unless resistance testing is done.
Delayed or missed diagnosis Symptoms often mimic other lung conditions. Late recognition allows infection or inflammation to cause irreversible damage.
Limited access to specialist care Some regions lack experienced clinicians, diagnostic testing, or antifungal drug availability, increasing global inequality in outcomes.
Drug toxicity and interactions Long-term antifungal therapy can affect the liver or interfere with other medicines if not closely monitored.
Environmental change Warmer, wetter climates and increased composting or construction may raise Aspergillus exposure for vulnerable people.
Healthcare strain and cost Long-term follow-up, monitoring, and expensive new drugs may challenge already stretched healthcare systems.

Each of these barriers needs attention through research, public health policy, and education to ensure the gains of the last 20 years continue.

❤️ The key message

Aspergillosis is still a serious disease, but its outlook is far better than it used to be.
With modern antifungals, biologics, and regular monitoring, most people live many years — and new treatments promise even better results.

Patients can help by:

  • Reporting new symptoms early.

  • Keeping up with regular blood and imaging checks.

  • Asking about resistance testing and treatment options.

  • Staying informed about new drugs and trials.

🌅 A hopeful future

In just twenty years, deaths from aspergillosis have halved.
If we continue improving diagnosis, drug development, and resistance control, survival will rise even higher — turning aspergillosis from a life-threatening infection into a long-term but manageable condition for most people.

by GAtherton

💬 Healthwatch: Your Local Voice in the NHS

Living with a long-term lung condition such as aspergillosis, asthma, or bronchiectasis often means regular contact with hospitals, GPs, and community clinics.
Sometimes things work well — and sometimes they don’t.
That’s where Healthwatch comes in.

Healthwatch is an independent organisation that represents patients and the public.
It exists to make sure your experiences help shape the way NHS and social-care services are delivered.

🏛️ What is Healthwatch?

Healthwatch was set up by law to be the official voice of patients and the public in health and social care.

There are two levels:

  • Healthwatch England – works nationally to influence NHS and government policy

  • Local Healthwatch – works in every local authority area across England, gathering feedback from people using local services

Healthwatch is not part of the NHS, and it’s not a complaints service, but it does have statutory powers to:

  • Listen to people’s experiences of care

  • Report issues and make recommendations to the NHS, local councils, and care providers

  • Request responses from organisations it investigates

  • Escalate serious concerns to the Care Quality Commission (CQC)

Learn more on the Healthwatch website.

🌿 Why Healthwatch matters to aspergillosis patients

People living with chronic lung disease often face delays, limited understanding, or difficulties accessing ongoing support.
Healthwatch helps make sure those experiences aren’t ignored.

1. Raising the patient voice

You can share your experience of healthcare — good or bad — with your local Healthwatch.
They collect stories from across the community and use them to:

  • Identify patterns (for example, problems with accessing respiratory clinics or antifungal monitoring)

  • Produce reports and recommendations for local NHS decision-makers

  • Push for improvements to long-term care pathways and community support

2. Helping to improve new neighbourhood health hubs

As NHS care moves into the community, Healthwatch plays a key role in making sure new Neighbourhood Health Hubs are:

  • Accessible for people with limited mobility or oxygen needs

  • Located where public transport and parking work for patients

  • Designed with chronic-illness patients in mind, not just short-term care

You can feed in your ideas through Healthwatch about what’s working and what isn’t in new NHS community models.

3. Providing information and signposting

If you’re unsure where to go for care — GP, hospital, or new health hub — or how to complain or appeal a service decision, Healthwatch can point you in the right direction.
They offer clear, local information about:

  • NHS patient transport

  • The Healthcare Travel Costs Scheme (HTCS)

  • Local support groups and community services

4. Supporting patient involvement

Healthwatch works with NHS organisations to include patients and carers in planning and reviewing services.
If you’d like to get involved as a patient representative or share your experience of aspergillosis services, Healthwatch can help you join local working groups or consultations.

5. Spotlighting inequalities

Healthwatch highlights where certain groups are left behind — for example:

  • People with rare or complex conditions

  • Patients in rural or deprived areas

  • Those unable to use digital appointment systems
    This helps ensure people with chronic lung conditions are not overlooked when new community-care models are designed.

⚖️ What Healthwatch can — and can’t — do

✅ Healthwatch can 🚫 Healthwatch can’t
Collect and report your experience to NHS leaders Fix individual clinical problems directly
Influence NHS and council decisions Guarantee faster treatment or appointments
Provide advice on local services and support Replace legal or complaints services
Escalate major safety concerns to the CQC Act as your personal advocate in disputes

Even so, their influence can be powerful — many improvements in NHS access and transport have started with patient stories collected by Healthwatch.

📍 How to contact your local Healthwatch

Every local area has its own Healthwatch website and phone number.
You can find yours at:
👉 Find your local Healthwatch

When you contact them, you can:

  • Fill in a short online form to share your story

  • Ask to join a focus group or consultation

  • Request accessible information or help finding services

  • Subscribe to local updates and reports

If you’d like support from the aspergillosis community, NAC CARES can also help you write or submit your feedback.

💬 Why this matters

“Nothing about us without us.”
Healthwatch exists so that patients — including those with rare and chronic conditions like aspergillosis — can make their experiences count.

By telling your story and feeding back to Healthwatch, you help shape better care for yourself and for others who will face similar challenges in future.

by GAtherton